Journal Information
Original
Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece
Prevalencia y factores de riesgo de efectos adversos tras la primera dosis de refuerzo de COVID-19: Datos procedentes de Grecia
Petros Galanisa,
, Aglaia Katsiroumpaa, Irene Vrakab, Vanessa Chrysagia, Olga Siskouc, Olympia Konstantakopouloud, Theodoros Katsoulase, Parisis Gallose, Daphne Kaitelidoud
Corresponding author
a Clinical Epidemiology Laboratory, Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece
b Department of Radiology, P. & A. Kyriakou Children's Hospital, Athens, Greece
c Department of Tourism Studies, University of Piraeus, Piraeus, Greece
d Center for Health Services Management and Evaluation, Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece
e Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece